High Costs, Low Margins, and Regulatory Hurdles Hinder Pharma’s Adoption of Advanced Manufacturing Technologies

Benchmark Banner Ad

 

The ongoing drug shortage crisis in the U.S. underscores a critical need for innovation in pharmaceutical manufacturing. As manufacturing issues, outdated technologies, and geopolitical risks contribute to shortages that impact patient care and elevate healthcare costs, the introduction of Advanced Manufacturing Technologies (AMTs) offers a beacon of hope. AMT technologies promise to enhance quality control and reduce production downtime, yet their adoption in generic drug production remains low despite obvious benefits.

Why is the pharmaceutical industry slow to adopt technologies that could revolutionize drug availability and cost?

Mike Tracy, a C-Level Healthcare Operations Strategist, dives into the complexities of integrating Advanced Manufacturing Technologies in drug production. Mike points out that while AMTs can drastically reduce bottlenecks in drug production, the significant initial investment and stringent regulatory landscape pose substantial hurdles.

“Every AMT has a high startup cost and generic drugs have very razor-thin margins to begin with. We’re not talking about a new drug that’s not already out in the market where you’re going to have a high margin and it makes sense to invest millions,” Tracy explains.

Article written by Sonia Gossai

Follow us on social media for the latest updates in B2B!

Image

Latest

healthcare
The Healthcare Talent Fix: Build Pipelines Early, Use Data, and Get the Experience Right
May 18, 2026

There’s a growing tension inside healthcare right now—between the people leaving the workforce and the patients still arriving every day. It’s a dynamic that leaders can no longer afford to ignore. The numbers make that clear: the Association of American Medical Colleges estimates that the U.S. could be short of as many as 86,000 physicians…

Read More
education
Just Thinking… About Federal Funds, Student Support, and the Future of Education with Eric Reaves
May 15, 2026

As conversations around the future of the U.S. Department of Education continue to intensify, educators and federal program leaders are facing mounting uncertainty about how federal funds will be managed, distributed, and regulated. At the same time, schools serving historically underserved students remain heavily reliant on programs like Title I and other federally…

Read More
trust
The Strongest Leaders Build Belief, Model Discipline and Earn Trust
May 14, 2026

Workplace leadership is under pressure: employees are continuing to disengage, and many managers are still trying to fix a trust problem with performance tactics. Gallup reported that U.S. employee engagement fell to 31% in 2024, its lowest level in a decade, and its research has found that managers account for at least 70% of…

Read More
medicine
The Art of Recovery: Where Music and Medicine Meet in Patient Care
May 14, 2026

Healthcare today can feel overwhelming—not just for patients, but for the teams caring for them. After a major illness or injury, recovery isn’t handled by one doctor alone; it often involves a whole network of specialists, from physical therapists to nurses to social workers, all trying to help someone regain their independence and quality…

Read More